DrugPatentWatch Database Preview

PF PRISM CV Company Profile

« Back to Dashboard

What is the competitive landscape for PF PRISM CV, and when can generic versions of PF PRISM CV drugs launch?

PF PRISM CV has fourteen approved drugs.

There are thirty-eight US patents protecting PF PRISM CV drugs.

There are eight hundred and eighty-two patent family members on PF PRISM CV drugs in sixty-six countries and eighty-two supplementary protection certificates in eighteen countries.

Summary for PF PRISM CV

International Patents:	882
US Patents:	38
Tradenames:	11
Ingredients:	11
NDAs:	14

Drugs and US Patents for PF PRISM CV

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Pf Prism Cv	BOSULIF	bosutinib monohydrate	TABLET;ORAL	203341-003	Oct 27, 2017		RX	Yes	No	7,417,148
Pf Prism Cv	ZMAX	azithromycin	FOR SUSPENSION, EXTENDED RELEASE;ORAL	050797-001	Jun 10, 2005		DISCN	Yes	No	6,984,403		Y
Pf Prism Cv	CHANTIX	varenicline tartrate	TABLET;ORAL	021928-002	May 10, 2006		RX	Yes	Yes
Pf Prism Cv	BOSULIF	bosutinib monohydrate	TABLET;ORAL	203341-002	Sep 4, 2012		RX	Yes	No	7,919,625		Y
Pf Prism Cv	BOSULIF	bosutinib monohydrate	TABLET;ORAL	203341-002	Sep 4, 2012		RX	Yes	No	7,767,678		Y	Y

Expired US Patents for PF PRISM CV

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Pf Prism Cv	RAPAMUNE	sirolimus	TABLET;ORAL	021110-002	Aug 22, 2002	5,403,833*PED
Pf Prism Cv	VFEND	voriconazole	TABLET;ORAL	021266-002	May 24, 2002	5,364,938
Pf Prism Cv	RAPAMUNE	sirolimus	TABLET;ORAL	021110-002	Aug 22, 2002	5,145,684*PED
Pf Prism Cv	RAPAMUNE	sirolimus	TABLET;ORAL	021110-001	Aug 25, 2000	5,989,591*PED
Pf Prism Cv	RAPAMUNE	sirolimus	SOLUTION;ORAL	021083-001	Sep 15, 1999	5,536,729*PED

Paragraph IV (Patent) Challenges for PF PRISM CV drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
	Tablets	1 mg and 2 mg		2009-12-17
	Extended-release Tablets	50 mg and 100 mg		2012-02-29
	Tablets	100mg and 500mg		2016-09-06
	Tablets	0.5 mg and 1 mg		2010-05-10
	Tablets	5 mg		2016-11-07
	For Injection	200 mg/vial		2008-09-12
	Oral Suspension	40 mg/mL		2010-10-08
	Injection	25 mg/mL, 1.8 mL vial		2011-05-25
	Tablets	0.5 mg		2010-08-25
	Extended-release Tablets	25 mg		2015-05-08
	Tablets	400 mg		2018-10-15
	Tablets	1 mg and 5 mg		2018-02-23
	Tablets	50 mg and 200 mg		2008-04-14
	For Injection	50 mg per vial		2009-06-15

International Patents for PF PRISM CV Drugs

Country	Patent Number	Estimated Expiration
Poland	365163
China	101326175
Brazil	0209246
Eurasian Patent Organization	011451
Georgia, Republic of	P20053454

Supplementary Protection Certificates for PF PRISM CV Drugs

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0648494	C300055	Netherlands		PRODUCT NAME: SIROLIMUS, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AAN- VAARDBAAR ZOUT; NATL. REGISTRATION NO/DATE: EU/1/01/171/001 - EU/1/01/171/005 20010313; FIRST REGISTRATION: CH CH/55243 20000926
1218348	PA2013003,C1218348	Lithuania		PRODUCT NAME: AXITINIBUM; REGISTRATION NO/DATE: EU/1/12/777/001 - EU/1/12/777/006 20120903
1666481	17C1031	France		PRODUCT NAME: TOFACITINIB,EVENTUELLEMENT SOUS LA FORME D'UN SEL PHARMACEUTIQUEMENT ACCEPTABLE,DONT LE CITRATE DE SODIUM; REGISTRATION NO/DATE: EU/1/17/1178 20170324
1044189	122008000038	Germany		PRODUCT NAME: VARENICLIN GEGEBENENFALLS IN FORM EINES PHARMAZEUTISCH ANNEHMBAREN SALZES UNTER EINSCHLUSS VON TARTRAT; REGISTRATION NO/DATE: EU/1/06/360/001-010 20060926
1218348	122013000016	Germany		PRODUCT NAME: AXITINIB, GEGEBENENFALLS IN FORM EINES PHARMAZEUTISCH ANNEHMBAREN SALZES; REGISTRATION NO/DATE: EU/1/12/777/001-006 20120903

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Pf Prism Cv